Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2024 | 08-2024 | 05-2024 | 02-2024 | 11-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,459 | 19,227 | -49,841 | -33,054 | -21,134 |
| Depreciation Amortization | 247 | 130 | 1,677 | 1,548 | 929 |
| Other Working Capital | -15,477 | -16,085 | 11,658 | 6,320 | 4,084 |
| Other Operating Activity | 2,625 | 2,168 | 25,524 | 15,854 | 9,124 |
| Operating Cash Flow | $1,854 | $5,440 | $-10,982 | $-9,332 | $-6,997 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,011 | 2,011 | 1,357 |
| Common Stock Issued | 10,377 | 10,377 | 9,437 | 5,996 | 3,316 |
| Other Financing Activity | -710 | -710 | 300 | 300 | 0 |
| Financing Cash Flow | $9,667 | $9,667 | $11,748 | $8,307 | $4,673 |
| Beginning Cash Position | 9,814 | 9,814 | 9,048 | 9,048 | 9,048 |
| End Cash Position | 21,335 | 24,921 | 9,814 | 8,023 | 6,724 |
| Net Cash Flow | $11,521 | $15,107 | $766 | $-1,025 | $-2,324 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,854 | 5,440 | -10,982 | -9,332 | -6,997 |
| Free Cash Flow | 1,854 | 5,440 | -10,982 | -9,332 | -6,997 |